Compounding pharmacies aren’t the only makers of off-brand versions of Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound. The ...

According to Bank of America, several companies are prime candidates for a stock split in the near future, which could lead ...

Court rulings against parts of Donald Trump's agenda put White House officials on the defensive. Hamas says it will not ...

KELOWNA, BC - Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW), a drug delivery platform innovator with a market capitalization of $29.84 million, has announced the issuance of two new patents by ...

New restrictions and safety checks on online pharmacies that prescribing high risk drugs, such as the weight loss drugs semaglutide and tirzepatide, could have a “significant” impact on GPs’ workload, ...

South Korea-based developer of RNAi therapeutics developer OliX Pharmaceuticals has announced a global licensing agreement with Eli Lilly.

Eli Lilly is paying up to $630m for a Phase I MASH candidate from OliX Pharmaceuticals, diversifying its pipeline with an RNA ...

Given the number of comorbidities associated with obesity, the market's growth will impact the entire cardiometabolic disease ...

While this condition can be caused by diabetes, tissue disease and neurological disorders, which damage the nerves and blood ...